Upgrade to SI Premium - Free Trial

Compass Point Starts ChronoScale (CHRN) at Buy

October 16, 2026 7:49 AM

Compass Point analyst Michael initiates coverage on ChronoScale (NASDAQ: CHRN) with a Buy rating and a price target of $25.00.


For an analyst ratings summary and ratings history on ChronoScale click here. For more ratings news on ChronoScale click here.


Shares of ChronoScale closed at $16.05 yesterday.

Categories

New Coverage